Abstract Pancreatic cancer is the 8th most common cause of cancer death for men and 9th for women worldwide with an incidence of approximately 10/100.000. Pancreatic ductal adenocarcinoma (PDAC) represents 85% of all cases of pancreatic cancer. Despite the constant efforts to develop novel diagnostic tools and treatment approaches, it is projected that PDAC would […]